AdvaMed selects MTI institute leader
This article was originally published in The Gray Sheet
Executive Summary
Trade group taps former University of Texas M.D. Anderson Cancer Center VP-International Business Development & Chief Marketing Officer Martyn Howgill to serve as executive director of its newly created Institute for Medical Technology Innovation (1"The Gray Sheet" March 8, 2004, p. 30). Member companies have contributed nearly $12.5 mil. to support the research and education body...
You may also be interested in...
Patient Access, Med Tech Value Research Top Collins’ Goals For AdvaMed
The Institute for Medical Technology Innovation raised just over $11 mil. in the first phase of its development campaign, AdvaMed announced at its annual meeting in Scottsdale, Ariz. March 5
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.